ADVFN - ニュース

S&P 500

5,477.90

0.16%

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

銘柄名/コード:

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/27	08 : 53	PR Newswire (Canada)	Le gouvernement du Canada lance une consultation publique sur l'infrastructure de calcul pour l'intelligence artificielle
2024/06/27	08 : 46	PR Newswire (Canada)	Government of Canada launches public consultation on artificial intelligence computing infrastructure
2024/06/27	08 : 45	GlobeNewswire Inc.	Announcement Regarding Filing of Annual Report on Form 20-F with the U.S. Securities and Exchange Commission	NYSE:MFG	Mizuho Financial Group Inc
2024/06/27	08 : 45	Business Wire	Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer	NYSE:MRK	Merck and Co Inc
2024/06/27	08 : 45	GlobeNewswire Inc.	Announcement Regarding Filing of Annual Report on Form 20-F with the U.S. Securities and Exchange Commission	8411.T
2024/06/27	08 : 43	Business Wire	Takeda kündigt neue Besetzung der Direktorenposten an	NYSE:TAK	Takeda Pharmaceutical Company Ltd
2024/06/27	08 : 43	Business Wire	Tamboran Prices US IPO at US$24.00 Per Share	ASX:TBN	Tamboran Resources Ltd
2024/06/27	08 : 31	Business Wire	Cognite reconnue comme partenaire de l'année 2024 de Microsoft en matière d'énergie et de ressources
2024/06/27	08 : 31	Business Wire	Cognite reconhecida como o Parceiro do Ano em Energia e Recursos da Microsoft em 2024
2024/06/27	08 : 30	NEWSBTC	Dogecoin Sees Rapid Accumulation Amid Price Crash, Whale Transactions Soar	COIN:SHIBUSD	SHIBA INU
2024/06/27	08 : 30	NEWSBTC	Dogecoin Sees Rapid Accumulation Amid Price Crash, Whale Transactions Soar	COIN:BTCUSD	Bitcoin
2024/06/27	08 : 30	NEWSBTC	Dogecoin Sees Rapid Accumulation Amid Price Crash, Whale Transactions Soar	COIN:MINAUSD	Mina
2024/06/27	08 : 30	NEWSBTC	Dogecoin Sees Rapid Accumulation Amid Price Crash, Whale Transactions Soar	COIN:FLOWUSD	Flow
2024/06/27	08 : 30	NEWSBTC	Dogecoin Sees Rapid Accumulation Amid Price Crash, Whale Transactions Soar	COIN:DOGEUSD	Dogecoin
2024/06/27	08 : 30	Business Wire	Chewy Announces $500 Million Repurchase of Shares from BC Partners	NYSE:CHWY	Chewy Inc
2024/06/27	08 : 27	PR Newswire (Canada)	Laramide Resources Announces Voting Results from its Annual Meeting of Shareholders	TSX:LAM	Laramide Resources Ltd
2024/06/27	08 : 26	PR Newswire (Canada)	METALLA ANNOUNCES VOTING RESULTS FROM ANNUAL GENERAL MEETING	TSXV:MTA	Metalla Royalty and Streaming Ltd
2024/06/27	08 : 26	PR Newswire (US)	METALLA ANNOUNCES VOTING RESULTS FROM ANNUAL GENERAL MEETING	AMEX:MTA	Metalla Royalty & Streaming Ltd
2024/06/27	08 : 26	PR Newswire (Canada)	METALLA ANNOUNCES VOTING RESULTS FROM ANNUAL GENERAL MEETING	AMEX:MTA	Metalla Royalty & Streaming Ltd
2024/06/27	08 : 25	Business Wire	Takeda annonce de nouvelles nominations de directeurs	NYSE:TAK	Takeda Pharmaceutical Company Ltd
2024/06/27	08 : 23	GlobeNewswire Inc.	Else Nutrition Announces US$2 Million Offering of Units Priced At-The-Market	TSX:BABY	Else Nutrition Holdings Inc
2024/06/27	08 : 18	GlobeNewswire Inc.	NASP Applauds the Senate Finance Chairman for Working to Address Unfair PBM Practices
2024/06/27	08 : 18	Business Wire	Arvest Bank and the Federal Home Loan Bank of Dallas Celebrate $15K Donation to Assist Affordable Housing Nonprofit
2024/06/27	08 : 12	PR Newswire (Canada)	Revised - Medical Facilities Corporation Announces Second Quarter Dividend	TSX:DR	Medical Facilities Corporation
2024/06/27	08 : 08	Business Wire	EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)	NASDAQ:GMAB	Genmab AS
2024/06/27	08 : 08	PR Newswire (US)	Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis
2024/06/27	08 : 05	PR Newswire (US)	2bcloud Recognized as Winner of 2024 Microsoft Partner of the Year Award
2024/06/27	08 : 05	GlobeNewswire Inc.	Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone	4565.T
2024/06/27	08 : 03	PR Newswire (US)	U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular Lymphoma	NYSE:ABBV	AbbVie Inc
2024/06/27	08 : 03	GlobeNewswire Inc.	EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)	TG:GE9	Genmab AS